Dr Paolo Casali talks to ecancer at the 2012 ESMO meeting in Vienna about personalised medical therapy of soft tissue sarcomas.

This approach involves using histology and tailoring therapy based on each tumours genomics.

These complicated procedures require a lot analysis with molecular biology had increases problems in developing clinical trials.

Dr Casali also talks about the announcement of the launch of Rare Cancers Europe at ESMO 2012. This multidisciplinary initiative looks at the issues of creating clinical studies for rare cancers in order to quicken the development of drugs for clincial use.

Filming supported by Amgen